4-(4-FLUORO-2-METHOXYPHENYL)-N-(3-((S-METHYLSULFONIMIDOYL)METHYL)PHENYL)-1,3,5-TRIAZIN-2-AMINE, 95%, 5mg

10,11-Dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine, 95+%, 250mg

1-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-5-oxo-pyrrolidine-3-carboxylic acid, 95.0%, 1g

2-Chloro-1H-benzimidazole, 97.0%, 5g

(2R,4R)-4-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95+%, 250mg

Methyl 2-((tert-butoxycarbonyl)amino)-2-(4-chlorophenyl)acetate, 97%, 100mg

6,7-Dihydro-5H-[1,2,4]triazolo[3,4-b][1,3]thiazin-3-ylamine, 95.0%, 1g

Methyl Pentafluorobenzoate>98.0%(GC)5g

Fmoc-HoCit-OH, 97%, 10g

2-Amino-3-(2-aminophenyl)propanoic acid, 95+%, 1g

1-(3,5-dinitrobenzoyl)-2-methylpiperazine, 95.0%, 5g

10,10'-Dibromo-9,9'-bianthracene>98.0%(HPLC)(T)5g

1-Bromo-4-(trans-4-propylcyclohexyl)benzene, 97%, 500g